Fundz

Remedy Plan Therapeutics raised $18M in funding to advance RPT1G, a novel NAMPT inhibitor, into Phase 1/2 trials for AML and MDS, led by Schooner Capital and Alexandria Venture Investments.

PRIVATEMay 13, 2025

Amount Raised

$18 Million

Round Type

Venture

GaithersburgBiotechnologyHealthcare

Investors

Alexandria Venture InvestmentsSchooner Capital

Description

Remedy Plan Therapeutics, a Gaithersburg, MD-based clinical-stage pharmaceutical company, raised $18M in funding. Backers included Schooner Capital, Alexandria Venture Investments, and other existing investors. The funds will accelerate the advancement of RPT1G, a novel NAMPT inhibitor, into a Phase 1/2 trial in patients with AML and MDS.

Quick answer

Remedy Plan raised $18 Million in a funding round, dated May 13, 2025. Investors: Alexandria Venture Investments and Schooner Capital. Remedy Plan is based in Gaithersburg, Maryland, United States.

How much did Remedy Plan raise?
Remedy Plan raised $18 Million in a funding round on May 13, 2025.
Who invested in Remedy Plan?
Alexandria Venture Investments and Schooner Capital are named as investors in this round.
What does Remedy Plan do?
Remedy Plan Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel, hyperbolic NAMPT inhibitors.
Where is Remedy Plan based and how big is it?
Remedy Plan is based in Gaithersburg, Maryland, United States.
Who are the decision-makers at Remedy Plan?
Fundz holds 1 contact at Remedy Plan, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Remedy Plan that raised within 45 days of this round, from Fundz verified event records.

  • Biofrontera raised $11M on June 27, 2025.
  • NewcelX raised $1M (Seed) on June 27, 2025.
  • Artelo Biosciences raised $1.4M (Seed) on June 26, 2025.
  • Endovia Health Sciences, Inc. raised $33M on June 25, 2025.
  • Os Therapies raised $4.2M on June 23, 2025.
  • ProPhase Labs raised $1M (Seed) on June 22, 2025.

Who to call at Remedy Plan, and when

A new round usually means Remedy Plan is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Remedy Plan raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Remedy Plan, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Remedy Plan. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Remedy Plan

Location

704 Quince Orchard Rd, Ste 220

Gaithersburg, Maryland, United States

About

Remedy Plan Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel, hyperbolic NAMPT inhibitors. NAMPT is an enzyme that controls how cells use energy and is core to human biology. It is dysregulated in more than 20 diseases spanning oncology, autoimmunity, and metabolic disorders. Previous efforts by others to inhibit NAMPT activity resulted in severe on-target toxicities in healthy tissues, which prevented meaningful clinical activity. Remedy Plan has developed a first-in-class approach to NAMPT inhibition that never fully turns NAMPT activity off. This selectively avoids on-target toxicity in healthy tissues while still meaningfully inhibiting NAMPT activity in diseased cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Remedy Plan raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsGregory C., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Remedy Plan's next move

See what Strategic adds

Remedy Plan raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.